213 related articles for article (PubMed ID: 3024542)
21. Intravenous immunoglobulin in bone marrow transplantation.
Gale RP; Winston D
Cancer; 1991 Sep; 68(6 Suppl):1451-3. PubMed ID: 1652350
[TBL] [Abstract][Full Text] [Related]
22. [Risk factors for the occurrence of pneumonia caused by cytomegaloviruses in patients with bone marrow transplants during prevention with cytomegalovirus hyperimmune globulin].
Schmeiser T; Heit W
Immun Infekt; 1985 Nov; 13(6):302-6. PubMed ID: 3000924
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent.
Kapoor N; Copelan EA; Tutschka PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3095-6. PubMed ID: 2539686
[No Abstract] [Full Text] [Related]
24. Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation.
Siadak MF; Kopecky K; Sullivan KM
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):53-7. PubMed ID: 8033436
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin.
Krischer J; Elfenbein G; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
Semin Hematol; 1992 Jul; 29(3 Suppl 2):89-95. PubMed ID: 1324530
[No Abstract] [Full Text] [Related]
26. Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis.
Bass EB; Powe NR; Goodman SN; Graziano SL; Griffiths RI; Kickler TS; Wingard JR
Bone Marrow Transplant; 1993 Sep; 12(3):273-82. PubMed ID: 8241987
[TBL] [Abstract][Full Text] [Related]
27. Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group.
Ljungman P; Engelhard D; Link H; Biron P; Brandt L; Brunet S; Cordonnier C; Debusscher L; de Laurenzi A; Kolb HJ
Clin Infect Dis; 1992 Apr; 14(4):831-5. PubMed ID: 1315585
[TBL] [Abstract][Full Text] [Related]
28. Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis.
Glowacki LS; Smaill FM
Clin Transplant; 1994 Feb; 8(1):10-8. PubMed ID: 8136560
[TBL] [Abstract][Full Text] [Related]
29. Prophylaxis of CMV infection in bone marrow transplant recipients by hyperimmune CMV gamma-globulin.
Condie RM; O'Reilly RJ
Dev Biol Stand; 1982; 52():501-13. PubMed ID: 6299859
[TBL] [Abstract][Full Text] [Related]
30. [Experiences with cytomegalovirus hyperimmunoglobulin after bone marrow transplantation].
Schmitz N; Gassmann W; Rautenberg P; Löffler H
Immun Infekt; 1985 Sep; 13(5):224-8. PubMed ID: 2998979
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A
Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924
[TBL] [Abstract][Full Text] [Related]
32. Interstitial pneumonia after allogeneic and autologous bone marrow transplantation.
Funada H; Harada M; Yoshida T; Hattori K
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():519-30. PubMed ID: 6097710
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation.
Bowden RA; Sayers M; Flournoy N; Newton B; Banaji M; Thomas ED; Meyers JD
N Engl J Med; 1986 Apr; 314(16):1006-10. PubMed ID: 3007984
[TBL] [Abstract][Full Text] [Related]
34. Intravenous immune globulin prophylaxis in recipients of a marrow transplant.
Sullivan KM
J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):632-8; discussion 638-9. PubMed ID: 2551949
[TBL] [Abstract][Full Text] [Related]
35. [Cytomegalovirus hyperimmune globulin and cytomegalovirus-tested blood products--a pilot study in bone marrow graft recipients].
Beelen DW; Neumann MC; Mahmoud HK; Henneberg K; Thraenhart O; Schaefer UW
Immun Infekt; 1985 Sep; 13(5):229-32. PubMed ID: 2998980
[TBL] [Abstract][Full Text] [Related]
36. Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation.
Elfenbein G; Krischer J; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
Transplant Proc; 1989 Feb; 21(1 Pt 3):3099-100. PubMed ID: 2539688
[No Abstract] [Full Text] [Related]
37. Cytomegalovirus infections after allogeneic bone marrow transplantation.
Winston DJ; Ho WG; Champlin RE
Rev Infect Dis; 1990; 12 Suppl 7():S776-92. PubMed ID: 2173107
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation.
Meyers JD; Flournoy N; Sanders JE; McGuffin RW; Newton BA; Fisher LD; Lum LG; Appelbaum FR; Doney K; Sullivan KM
Ann Intern Med; 1987 Dec; 107(6):809-16. PubMed ID: 2825571
[TBL] [Abstract][Full Text] [Related]
39. Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease.
Snydman DR
Rev Infect Dis; 1990; 12 Suppl 7():S839-48. PubMed ID: 2173113
[TBL] [Abstract][Full Text] [Related]
40. The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients.
Petersen FB; Bowden RA; Thornquist M; Meyers JD; Buckner CD; Counts GW; Nelson N; Newton BA; Sullivan KM; McIver J
Bone Marrow Transplant; 1987 Aug; 2(2):141-7. PubMed ID: 2844338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
